We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$229M
Cap. Flow
-$115M
Cap. Flow %
-7.69%
Top 10 Hldgs %
22.33%
Holding
2,451
New
741
Increased
498
Reduced
386
Closed
708

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$48.3M
2
COL
Rockwell Collins
COL
+$34.6M
3
DELL icon
Dell
DELL
+$33.7M
4
CA
CA, Inc.
CA
+$33.7M
5
NXPI icon
NXP Semiconductors
NXPI
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 11.52%
2 Communication Services 10.15%
3 Healthcare 7.28%
4 Consumer Discretionary 5.72%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBLK icon
1301
Star Bulk Carriers
SBLK
$3.22B
$13K ﹤0.01%
1,394
+560
+67% +$6.13K
SHO icon
1302
Sunstone Hotel Investors
SHO
$2.06B
$13K ﹤0.01%
+1,001
New +$14.7K
UNFI icon
1303
CALL
United Natural Foods
UNFI
$2.85B
$13K ﹤0.01%
+1,200
New +$25.2K
UTMD icon
1304
Utah Medical Products
UTMD
$225M
$13K ﹤0.01%
+157
New +$13.8K
VIVO
1305
DELISTED
Meridian Bioscience Inc
VIVO
$13K ﹤0.01%
752
-510
-40% -$8.7K
SPNE
1306
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$13K ﹤0.01%
697
+322
+86% +$5.44K
AFI
1307
DELISTED
Armstrong Flooring, Inc.
AFI
$13K ﹤0.01%
1,100
-200
-15% -$3.07K
MYOK
1308
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$13K ﹤0.01%
260
+121
+87% +$6.66K
CVLT icon
1309
CALL
Commault Systems
CVLT
$5.61B
$12K ﹤0.01%
+200
New +$11.8K
EVER icon
1310
EverQuote
EVER
$906M
$12K ﹤0.01%
+2,920
New +$27.1K
FCN icon
1311
FTI Consulting
FCN
$4.18B
$12K ﹤0.01%
180
-385
-68% -$25.9K
FLWS icon
1312
1-800-Flowers.com
FLWS
$258M
$12K ﹤0.01%
966
HZO icon
1313
MarineMax
HZO
$788M
$12K ﹤0.01%
676
+270
+67% +$5.63K
KALV
1314
DELISTED
KalVista Pharmaceuticals
KALV
$12K ﹤0.01%
597
-59
-9% -$1.19K
KBR icon
1315
KBR
KBR
$4.8B
$12K ﹤0.01%
780
-679
-47% -$12.7K
LLY icon
1316
PUT
Eli Lilly
LLY
$1.06T
$12K ﹤0.01%
+100
New +$11.2K
RYAM icon
1317
Rayonier Advanced Materials
RYAM
$610M
$12K ﹤0.01%
1,148
-652
-36% -$8.87K
SMTC icon
1318
Semtech
SMTC
$13B
$12K ﹤0.01%
+265
New +$12.6K
STRT icon
1319
STRATTEC Security
STRT
$361M
$12K ﹤0.01%
+400
New +$12.9K
TXT icon
1320
Textron
TXT
$15.4B
$12K ﹤0.01%
+269
New +$15.1K
UGI icon
1321
UGI
UGI
$7.33B
$12K ﹤0.01%
231
WEYS icon
1322
Weyco Group
WEYS
$440M
$12K ﹤0.01%
428
EGRX
1323
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$12K ﹤0.01%
289
+153
+113% +$7.88K
DOOR
1324
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$12K ﹤0.01%
+277
New +$15K
NVTA
1325
DELISTED
Invitae Corporation
NVTA
$12K ﹤0.01%
1,088
-43,906
-98% -$569K

Similar funds

Prelude Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Prelude Capital Management held 2,451 positions worth $1.49B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management withdrew a net $115M in Q4 2018, closing 708 positions and reducing 386 holdings. Its most notable exit was Aetna Inc, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Red Hat Inc worth $33.2M.

  • Prelude Capital Management's largest Q4 2018 buy was Red Hat Inc: 189,248 shares worth $33.2M.
  • Prelude Capital Management added most to Athenahealth, Inc. in Q4 2018, an estimated $16M increase.
  • Prelude Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $33.7M.
  • Prelude Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $48.3M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.49B portfolio in Q4 2018.
  • Prelude Capital Management opened 741 new positions and closed 708 in Q4 2018.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.